Best Grants for Cancer Nonprofits in Guam

The R01 grant program aims to address disparities in liver diseases and liver cancer in the United States. It supports multi-level intervention research targeting populations with significant health disparities. With deadlines spanning from February 2024 to June 2027, this initiative encourages innovative approaches to improve health outcomes in underserved communities, ultimately enhancing public health and reducing inequities in healthcare access and treatment.

Research institutions and similar organizations studying tobacco, alcohol, or cannabis policy impacts on cancer-related health equity can apply for up to US $2,500,000 in Guam and across the U.S. NIH provides Guam cancer and health disparities researchers with funding to evaluate policies, engage community partners, and reduce exposure among populations experiencing disparities.

The National Cancer Institute's PAIRS program aims to explore innovative cancer therapies by leveraging synthetic vulnerabilities that interact with tumor responses to radiation therapy. This initiative supports the development of targeted drug-radiation combinations, focusing on precision medicine to optimize treatment efficacy while minimizing harm to normal tissues. By consolidating prior funding opportunities, PAIRS encourages research that addresses context-dependent vulnerabilities, enhancing therapeutic strategies and aligning with NIH's scientific goals.

The Cancer Center Support Grants (CCSGs) aim to bolster NCI-Designated Cancer Centers by funding comprehensive, clinical, and basic cancer research. These grants facilitate the integration of diverse research capabilities, promoting innovative approaches to cancer prevention, diagnosis, and therapy. CCSGs encourage collaboration among researchers and the development of Shared Resources, ultimately enhancing the understanding of cancer and its treatment. This initiative supports the continuous discovery and dissemination of crucial research findings for community benefit.

The National Cancer Institute (NCI) invites research applications focused on early-onset cancers (ages 18-49), aiming to uncover their etiology and biological mechanisms. This funding opportunity supports studies that explore modifiable risk factors, biological responses, and improved identification of at-risk individuals. The initiative seeks to address the concerning rise in these cancers among young adults, facilitating essential prevention and control strategies. Applicants can choose between exploratory or research project formats, with project durations ranging from 2 to 5 years.

The National Cancer Institute's STRIPE program aims to advance cancer therapy by investigating the effects of radionuclide-emitted radiation. This initiative encourages multidisciplinary research to understand how radiation impacts normal tissues and tumor cells, ultimately improving therapeutic outcomes. By consolidating various funding mechanisms, STRIPE seeks to lower entry barriers for researchers, enhance the scientific foundation of radiopharmaceutical therapy, and foster innovative treatment strategies. Projects can be exploratory or research-focused, with flexible timelines for completion.

Cancer research institutions and clinical teams in Guam and other eligible U.S. territories can seek funding to integrate imaging and liquid biopsy tumor monitoring during cancer therapy. Focused on advancing cancer/oncology and biomedical imaging, the National Institutes of Health supports R01 projects that optimize these modalities for assessing treatment response and emerging resistance, with awards up to US $2,500,000.

Nonprofit and research organizations developing cancer biomarker assays for detection, diagnosis, prognosis, or treatment response can apply for up to US $275,000 from the National Institutes of Health, including projects in Guam. With a mission to advance cancer research, NIH supports analytical (UH2) and clinical (UH3) validation of high-quality assays using human samples.

Cancer research institutions and clinical laboratories in Guam working on biomarker assays for cancer detection, diagnosis, or treatment response can access funding through the National Institutes of Health. Awards up to US $750,000 support clinical validation of analytically validated molecular, cellular, or imaging markers and harmonization of assay performance across studies and laboratories.

Guam cancer and health-disparities research organizations can access funding through the National Institutes of Health to test clinical trials that expand cancer screening and preventive services. Projects must address barriers and facilitators to screening and follow-up in populations experiencing health disparities, working at multiple levels and in collaboration with community partners and healthcare providers.

The National Cancer Institute (NCI) is set to release a Notice of Funding Opportunity (NOFO) aimed at advancing informatics technologies for cancer research. This initiative will support the development of tools that enhance data acquisition, management, and analysis throughout the cancer continuum. By focusing on technologies with proven impact, the NOFO seeks to optimize and sustain resources critical for cancer biology, diagnosis, treatment, and epidemiology.

The Research Scholar Grants (RSG) by the American Cancer Society support independent researchers engaged in cancer-related studies. Eligible applicants must be affiliated with US academic institutions and have been appointed as independent faculty for less than ten years. Grants provide funding up to $215,000 annually for direct costs and allow for 10% indirect costs, with project durations of up to four years, fostering innovative cancer research across various priority areas.

The ACS Professor Award, presented by the American Cancer Society, recognizes full professors who have significantly advanced cancer research. This honorific award aims to support innovative pursuits in cancer research with a budget of up to $80,000 per year for five years. Applicants are expected to demonstrate impactful contributions and leadership in the field, along with a commitment to mentorship and community engagement. The award highlights the importance of ongoing advocacy and research in improving cancer treatment and prevention.

The Health Promotion and Disease Prevention Research Centers are offering supplemental funding for Special Interest Projects (SIPs) aimed at enhancing public health practices. These projects will focus on innovative health promotion and disease prevention strategies to mitigate leading health risks in the U.S. The initiative supports ten specific SIPs, including studies on cancer care, alcohol use reduction, and emergency preparedness, thereby fostering research that translates into real-world health improvements.

The CDC's initiative focuses on developing clinical decision support (CDS) tools for cancer screening and management, specifically for cervical, breast, and colorectal cancers. The project aims to enhance guideline-concordant screening and improve management processes through rigorous implementation and evaluation within large health systems. By integrating these tools into electronic health records, the initiative seeks to support clinicians in making evidence-based decisions at the point of care, ultimately improving patient outcomes in cancer care.

Cancer research institutions and medical centers in Guam and other eligible U.S. locations can seek support to run institutional career development programs for clinical oncology researchers. US Dept. of Health & Human Services: National Institutes of Health provides funding for K12 programs that train clinician-scientists in clinical and translational cancer research through mentored, multi-year scholar appointments.

Oncology Nursing Foundation

The mission of the Oncology Nursing Foundation is to support cancer nursing excellence.

Since 1981, the Oncology Nursing Foundation(ONF), through generous contributions from individuals and institutions, has provided more than $33 million in funding to support oncology nursing education, research and leadership development. This funding has translated to career development awards, academic scholarships, research grants, a myriad of specialized educational initiatives, as well as nurse resiliency support. The Foundation’s activities have played a critical role in improving patient care and advancing the oncology nursing profession.

Radiation Oncology Certified Nurse (ROCN™) Exam Scholarship

Recipients receive funding to cover the ONCC ROCN™ Certification exam fee.

Purpose

To support registered oncology nurses who specialize in providing care for adult or pediatric patients with cancer undergoing radiation therapy by providing funding support to cover the ROCN™ Certification exam fee. 

The National Mesothelioma Virtual Bank (NMVB) aims to enhance biomedical research on malignant mesothelioma by expanding its collection of biospecimens, including tumor tissues and blood samples, alongside demographic and clinical data. Established in 2006, the NMVB serves as a crucial resource for researchers, providing access to a diverse library of samples and data, which can help identify disease markers and develop improved treatment options. This initiative is essential for advancing the understanding and treatment of mesothelioma.

Research institutions studying cancer mechanisms after bariatric surgery in Guam and other eligible U.S. territories can apply for National Institutes of Health funding; awards up to US $275,000 support feasibility and exploratory development studies. Projects must investigate how bariatric surgery influences cancer risk, rather than short-term outcomes like weight loss or diabetes.

The National Cancer Institute (NCI) invites applications for the R33 grant aimed at advancing emerging technologies in cancer research. This funding opportunity seeks projects that demonstrate significant progress in technology development, focusing on cancer biology, early detection, and clinical diagnosis. Eligible proposals must showcase innovative methodologies that enhance research capabilities, with a strong emphasis on technical validation and broad applicability in cancer applications.

The National Cancer Institute (NCI) invites applications for innovative technologies aimed at cancer research and clinical care. This funding opportunity supports early-stage projects focused on proof-of-concept studies to assess the feasibility of new methods and tools. Applications should demonstrate significant technical innovation, targeting advancements in cancer biology, early detection, clinical diagnosis, treatment, and epidemiology. Technologies may include novel analysis platforms, imaging technologies, and biospecimen processing innovations, with a focus on cancer applications.

The FY26 Kidney Cancer Research Program's Idea Development Award supports innovative research that enhances understanding of kidney cancer, aimed at improving patient outcomes. Proposals should feature a strong hypothesis and a detailed research plan, with team members experienced in kidney cancer research. A unique aspect is the Partnering Principal Investigator option, fostering collaboration between two investigators, ensuring comprehensive project development while allowing for distinct submissions. This award emphasizes impactful partnerships to drive advancements in the field.

The National Cancer Institute (NCI) invites applications for transformative research in cancer biology and oncology through nanotechnology. This funding opportunity aims to address significant challenges by exploring the interactions of nanomaterials with biological systems. Projects should focus on utilizing nanoparticles and devices for targeted cancer therapies and enhancing diagnostic capabilities. Successful proposals will contribute to the foundational knowledge necessary for future nanotechnology-based interventions in cancer treatment.

Research institutions and similar organizations studying tobacco, alcohol, or cannabis policies and their effects on health can apply for funding up to US $275,000 from the National Institutes of Health. Grants from NIH help Guam cancer and health equity researchers partner with community organizations to examine policy impacts on substance use, exposure, and cancer prevention among populations experiencing disparities.

Research institutions and universities in Guam working on cancer and biomedical imaging can access funding through the National Institutes of Health to develop molecular imaging methods for studying inflammation in cancer in vivo. Awards up to US $2,500,000 support integrated pre-clinical and clinical imaging research and cross-field collaboration between cancer scientists and imaging experts.

The National Cancer Institute's Youth Enjoy Science Research Education Program (R25) aims to enhance educational opportunities in biomedical research for underrepresented students in grades 6-12 and undergraduates. By fostering diverse participation, the program seeks to inspire interest in cancer research careers and strengthen essential research skills through hands-on experiences. This initiative aligns with the NIH's mission to support education and training in health sciences, ultimately contributing to a more inclusive research community.

The FY26 Peer Reviewed Cancer Research Program's Idea Award promotes innovative, high-risk cancer research initiatives. It supports groundbreaking concepts that advance cancer knowledge, patient care, and treatment options within the Military Health System. Projects must demonstrate creativity and innovation, avoiding incremental advancements. Notably, the Early Career Investigator Option is available to foster the growth of promising new investigators early in their careers. This award aims to make significant contributions to cancer research for Service Members and Veterans.